Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1984Annals of Internal Medicine

BCVPP Chemotherapy for Advanced Hodgkin's Disease: Evidence for Greater Duration of Complete Remission, Greater Survival, and Less Toxicity Than with a MOPP Regimen

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRichard BakemeierStrong Memorial Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Richard Bakemeier (1984) studied this question.

synapsesocial.com/papers/6a84b00f840a38e44ae11485https://doi.org/10.7326/0003-4819-101-4-447
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-bleomycin in the management of advanced Hodgkin-s disease a southwest oncology group study1983 · 43 citations
  2. 2Toxicity and response criteria of the Eastern Cooperative Oncology Group1982 · 11,821 citations
  3. 3The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease. A follow-up report1980 · 38 citations
  4. 4The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lecture1981 · 165 citations